secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001773751-25-000059
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers FY2024 revenue $1.48B (+69% YoY); net income $126M vs loss; guides FY2025 rev $2.3-2.4B
--------------------------------------------------------------------------------

- Revenue $1.48B for FY2024, up 69% YoY; Q4 revenue $481M, up 95% YoY.
- Net income $126M for FY2024 vs net loss $23.5M FY2023; Adjusted EBITDA $177M.
- Subscribers reached 2.2M, up 45% YoY; Monthly Online Revenue per Avg Subscriber $64.
- FY2025 revenue guidance $2.3-2.4B; Adjusted EBITDA $270-320M.
- Q4 gross margin 77% vs 83% prior year; weight loss GLP-1 offering drives acceleration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375125000059/0001773751-25-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375125000059/hims-20250224.htm
  HTML page:      https://secwatch.observer/filing/0001773751-25-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer